Entries by Andrew Humphreys

, , , , , , , , , , , , , ,

Three Companies Shutter Clinical Programs

Three biopharma companies recently shuttered their clinical programs after either their drug compounds failed clinical trials or interim futility analysis suggested they were unlikely to meet their clinical endpoints.

, , , , , , , , , , ,

McKesson says states seek $21 billion from drug distributors in opioid settlement

McKesson Corp. said the company and two other major U.S. drug distributors could be expected to pay up to $21 billion under a new proposal by state attorneys general to resolve lawsuits alleging they helped fuel the U.S. opioid crisis.

, , , , , , , ,

U.S. experts to review Biogen drug that could be first new Alzheimer’s treatment in decades

U.S. health experts this week will decide whether to recommend approval for Biogen Inc.’s experimental Alzheimer’s drug, which could become the first new treatment for the mind-wasting disease in decades even as serious questions persist over whether data show if the antibody aducanumab works.

, , , , ,

FCB Health Network’s #WhyVote Storytelling Campaign is Inspiring and Empowering Americans to Vote

In early October, FCB Health Network proudly launched #WhyVote, a non-partisan campaign that uses the power of storytelling to inspire and empower Americans to vote. On October 30, FCB Health Network partnered with Black Rock Coalition and Club House Global to host the apex of the #WhyVote initiative’s 2020 efforts: #WhyVote Live – A Virtual Pep Rally to the Polls.

, , , , , , , , , , , , ,

As U.S. Covid-19 cases break records, weekly deaths rise 3%

The number of new Covid-19 cases in the United States hit another record high, rising 18% week-over-week to more than 575,000, while deaths inched up 3%, according to a Reuters analysis of state and county reports.